Bolt Biotherapeutics (BOLT) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 10, 2026, to be held virtually for shareholders of record as of April 22, 2026.

• Shareholders can vote online, by phone, mail, or virtually at the meeting.

• Proxies are solicited by the Board, with shares voted as directed or per Board recommendations if no direction is given.

Voting matters and shareholder proposals

• Election of two Class II director nominees, William P. Quinn and Jakob Dupont, M.D., to serve until the 2029 annual meeting.

• Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for the year ending December 31, 2026.

• Authorization to conduct any other business properly brought before the meeting.

Board of directors and corporate governance

• Board recommends voting FOR all proposals presented at the annual meeting.

• Proxies confer discretionary authority to vote on additional matters that may arise during the meeting.